Press Releases

Date	Title
5/18/23	Pulse Biosciences’ Nanosecond Pulsed Field Ablation (nsPFA™) Technology to be Featured in Several Presentations at The Heart Rhythm 2023 Annual Meeting
5/11/23	Pulse Biosciences Reports Business Updates and First Quarter 2023 Financial Results
5/10/23	Pulse Biosciences, Inc. Announces Planned Redemption of Warrants
5/3/23	Pulse Biosciences, Inc. Appoints Dr. Gan Dunnington as Chief Medical Officer
5/1/23	Pulse Biosciences Announces $65 Million Private Placement
4/27/23	Pulse Biosciences Schedules First Quarter 2023 Financial Results Conference Call for May 11, 2023
3/30/23	Pulse Biosciences Reports Fourth Quarter & Full Year 2022 Financial Results
3/2/23	Pulse Biosciences Schedules Fourth Quarter & Full Year 2022 Financial Results Conference Call for March 30, 2023
2/2/23	Pulse Biosciences Announces Its Novel Nanosecond Pulsed Field Ablation System Will Be Highlighted at the 2023 AF Symposium
11/10/22	Pulse Biosciences Reports Third Quarter 2022 Financial Results

Keyword Search